Self-help behaviors partially mediate the relationship between personalized depression risk disclosure and psychological distress: A mediation analysis using data from a randomized controlled trial.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
08 2021
Historique:
received: 15 03 2021
revised: 03 05 2021
accepted: 18 05 2021
pubmed: 5 6 2021
medline: 6 8 2021
entrez: 4 6 2021
Statut: ppublish

Résumé

Major depressive disorder (MDD) is one of the most prevalent forms of mental illness. Multivariate risk predictive (MVRP) algorithms provide a new means of identifying high-risk individuals for mental health disorders. Self-help behaviors may provide accessible methods to mitigate depression risk. The objective of this study is to investigate the mediating effects of self-help behavior on the relationship between depression risk disclosure and psychological distress. A sample (n = 556) of high-risk Canadians for a major depressive episode (MDE) were randomized into risk-disclosure or control groups and followed-up at 6 and 12 months. Mediation analysis using repeated measure mixed effects models was used to investigate the mediating effects of self-help behaviors on the relationship between depression risk disclosure and psychological distress over time. Self-help behavior was found to partially mediate the relationship between risk disclosure and psychological distress at month 12. Both unadjusted and adjusted associations were found to be negative and significant (ß

Identifiants

pubmed: 34087753
pii: S0022-3956(21)00317-4
doi: 10.1016/j.jpsychires.2021.05.047
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-14

Subventions

Organisme : CIHR
ID : PJT-148537
Pays : Canada

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Emily Warner (E)

The Institute of Mental Health Research, University of Ottawa, 1145 Carling Ave, Ottawa, Ontario, K1Z 7K4, Canada. Electronic address: Emily.Warner@theroyal.ca.

Molly Nannarone (M)

The Institute of Mental Health Research, University of Ottawa, 1145 Carling Ave, Ottawa, Ontario, K1Z 7K4, Canada. Electronic address: Molly.Nannarone@theroyal.ca.

Douglas Manuel (D)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Room 101, Ottawa, Ontario, K1G 5Z3, Canada; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa Hospital Research Institute, 501 Smyth Box 511, Ottawa, Ontario, K1H 8L6, Canada; Department of Family Medicine, Faculty of Medicine, University of Ottawa, 600 Peter Morand Cresc, Suite 20, Ottawa, Ontario, K1G 5Z3, Canada. Electronic address: dmanuel@ohri.ca.

Bonnie Lashewicz (B)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3D10, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada. Electronic address: bmlashew@ucalgary.ca.

Scott Patten (S)

Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3D10, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada; Department of Psychiatry, Cumming School of Medicine, University of Calgary, 1403 - 29 Street NW, Calgary, Alberta, T2N 2T9, Canada. Electronic address: patten@ucalgary.ca.

Norbert Schmitz (N)

Department of Psychiatry, Faculty of Medicine, McGill University, 1033 Pine Avenue West, Montreal, Quebec, H3A 1A1, Canada. Electronic address: norbert.schmitz@mcgill.ca.

JianLi Wang (J)

The Institute of Mental Health Research, University of Ottawa, 1145 Carling Ave, Ottawa, Ontario, K1Z 7K4, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, 600 Peter Morand Crescent, Room 101, Ottawa, Ontario, K1G 5Z3, Canada. Electronic address: jianli.wang@theroyal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH